Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 28.34 -0.72 (2.48%)
Previous Close $29.06    52 Week High
Open $28.71    52 Week Low
Day High $29.30    P/E N/A 
Day Low $28.26    EPS
Volume 653,069